Discrimination of Lycium chinense and L. barbarum Based on Metabolite Analysis and Hepatoprotective Activity

Volume: 25, Issue: 24, Pages: 5835 - 5835
Published: Dec 10, 2020
Abstract
Lycii Fructus is a traditional medicine used to prevent liver and kidney diseases, which commonly derives from Lycium chinense and Lycium barbarum. Here, the extracts and ethyl acetate-soluble fractions of L. chinense fruits exhibited better hepatoprotective effects than those of L. barbarum, which was likely due to differences in their composition. Therefore, GC-MS and HPLC analyses were conducted to characterize the metabolite differences...
Paper Details
Title
Discrimination of Lycium chinense and L. barbarum Based on Metabolite Analysis and Hepatoprotective Activity
Published Date
Dec 10, 2020
Journal
Volume
25
Issue
24
Pages
5835 - 5835
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.